You are here: Home » Current Affairs » Coronavirus » News
Business Standard

The story behind the rise of Serum Institute, world's vaccine factory

Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses

Topics
Serum Institute of India | Coronavirus Vaccine | Indian pharma companies

Vinay Umarji  |  Ahmedabad 

serum institute, coronavirus, covid, vaccine, pharma
Serum’s strength is its ability to identify the market need quickly, and bring down prices of newer vaccine, which it did with Hepatitis-B (2001) and BCG (2002)

It all began from a small laboratory producing tetanus anti-toxin in a corner of a stud farm in a peri-urban locality, with an investment of $12,000 in 1967. That first small unit, founded by industrialist Cyrus Poonawalla in Hadapsar, which connects Pune to the erstwhile textile-mill town of Solapur, has today grown into the (SII) — a mammoth commanding 50 per cent of the global vaccine industry.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, January 02 2021. 06:10 IST
RECOMMENDED FOR YOU